Cross-sex hormone therapy for gender dysphoria

@article{Fabris2015CrosssexHT,
  title={Cross-sex hormone therapy for gender dysphoria},
  author={Bruno Fabris and Stella Bernardi and Claudia Maria Trombetta},
  journal={Journal of Endocrinological Investigation},
  year={2015},
  volume={38},
  pages={269-282}
}
PurposeGender identity is the sense one has of being male or female. Gender dysphoria (GD) refers to the distress caused by the incongruence between gender identity and biological sex in gender-nonconforming individuals. Cross-sex hormone therapy (CHT) aims at easing GD, improving well-being, and quality of life of gender-nonconforming individuals. This can be achieved by inducing and maintaining the desired-sex characteristics in accordance with the specific aspirations and expectations of… 
View on Springer
arts.units.it
26 Citations
Highly Influential Citations
2
Background Citations
9

26 Citations

Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services

There is an urgent need for the implementation of different and innovative health care services for TGNC individuals as well as more targeted prevention strategies on such underreported and highly risky behaviours.

Andrology of male‐to‐female transsexuals: influence of cross‐sex hormone therapy on testicular function

There is a need for more individualized and better‐controlled cross‐sex hormone therapy and post‐treatment regimens, and evidence‐based guidelines for attending clinicians need to be established in order to deliver the most appropriate care.

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study

The findings support the benefit of initiating masculinising or feminising GAHT for gender dysphoria and emotional well-being and social functioning within 6 months of treatment.

Discrimination and psychopathology in gender dysphoria: a hormone therapy

CHT could affect the mental health of people with gender dysphoria, and it was concluded that male-to-female people with Gender dysphoria on CHT had lower psychological problems than those who did not receive hormone therapy.

Gender identity and the management of the transgender patient: a guide for non-specialists

It is shown that gender reassignment can be a safe and effective treatment for gender dysphoria with counselling, exogenous hormones and surgery being the mainstay of treatment.

Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery.

Terapia hormonal en la transición femenino a masculino (ftm), androgénica, para trans masculino o para hombre transgénero

Hormonal Therapy of the female to male transition (FTM) is focused only on people who transit from woman to man, or male trans, male transgender.

Current use of testosterone therapy in LGBTQ populations

Although TT is an effective treatment for many patients, there has been an increase in the illegitimate acquisition of TT in recent years and non-judicious prescribing and lack of physician surveillance increases the risk of unintended side effects and potential serious health consequences.

Challenges in assessing personality of individuals with Gender Dysphoria with the SWAP-200

A brief guide to the use of SWAP-200 with transgender patients is provided, taking into account three areas of psychological functioning: identity, relationships and sexuality.

Quality of life and hormones after sex reassignment surgery

Transpeople’s QoL turns out to be similar to Italian matched controls and LH resulted inversely correlated to body image and sexual life scores, highlighting general satisfaction after SRS.

References

SHOWING 1-10 OF 93 REFERENCES

Endocrine intervention for transsexuals

This review discusses predisposing factors to transsexualism, and the diagnosis, assessment and hormone treatment of transsexual patients, and discusses the risks and organ-specific effects of crosssex hormone treatment.

Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria.

The differences observed between MtF and FtM individuals suggest that body-related uneasiness associated with GD may be effectively diminished with the administration of CHT even without the use of genital surgery for MtF clients.

Safety of hormonal treatment in transgenders

Treatment must be highly individualized and transitioning patients need to be engaged in a ‘clinical contract’ with the physician in order to ensure compliance with prescribed treatments.

Endocrinologic treatment of gender identity disorders.

Physicians caring for patients with transsexualism should have a general knowledge about the diagnosis, available treatment, and monitoring for complications of hormonal therapy.

Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.

Cross-sex hormone treatment of transsexuals seems acceptably safe over the short and medium term, but solid clinical data are lacking.

Medical Management of Adult Transsexual Persons

Methods, including both pharmacotherapy and surgical interventions, are described for effective medical management of both male and female adults with GID, an increasingly recognized medical condition with an expanding body of medical literature to support the use of established therapeutic guidelines.

Hormone Treatment of the Adult Transsexual Patient

  • L. Gooren
  • Medicine, Biology
    Hormone Research in Paediatrics
  • 2005
The goal of treatment in female-to-male transsexuals is to induce virilization, including a male pattern of sexual hair, a male voice and male physical contours, and to stop menses.

Conjectures concerning cross-sex hormone treatment of aging transsexual persons.

Cross-sex hormones may be continued into old age but monitoring for cardiovascular disease and malignancies, both of the old and new sex, is recommended.

Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7

This version of the SOC recognizes that treatment for gender dysphoria has become more individualized, and can be used to help patients consider the full range of health services open to them, in accordance with their clinical needs and goals for gender expression.

Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.

It is concluded that cross-sex hormone treatment of male-to-female transsexuals using GnRHa and oestradiol-17beta valerate is effective, and side effects and complication rates can be reduced using the treatment regimen presented here.
...